Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin Empirical Therapy in Chinese Adults
NCT00548080Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2006
- Primary completion
- Nov 2006
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of caspofungin in fungal infection, sponsored by Merck & Co.. Started Mar 2006; status: completed.
02
Drugs
caspofungin
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00548080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548080.